These results, along with a earlier report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 help the strategy of targeting ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-relevant Diseases. Disclaimer: The above is actually a https://scottg702dus1.wikitelevisions.com/user